S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.10 (+0.14%) NASDAQ 26,517.93 ▲ 496.23 (+1.91%) US Markets Closed â€ĸ 05:07 AM ET

PRFX

PRF Technologies Ltd.

Price Chart
Latest Quote

$1.65

-0.20 (-10.81%)
Current Price
Previous Close $1.85
Open $1.66
Day High $1.74
Day Low $1.39
Volume 456,984
Fetched: 2026-06-22T09:07:01
Stock Information
Shares Outstanding 3.02M
Total Debt $21K
Cash Equivalents $4.14M
Revenue $17K
Net Income $-4.84M
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Market Cap $4.99M
EPS (TTM) $-7.47
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$-1.98M
Sales$17K
Income$-4.84M
Book/sh$10.29
Cash/sh$1.37
Employees6
Financial Ratios
Quick Ratio1.75
Current Ratio1.78
Debt/Eq0.23
Returns & Margins
ROA-38.75%
ROE-90.37%
Operating Margin-16200.00%
Ownership
Insider Ownership0.07%
Institutional Ownership2.92%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-0.14
P/S293.27
P/B0.16
Analyst Data
Recommendationnone
Technical Indicators
SMA20$1.72
SMA50$1.96
SMA200$3.93
RSI32.65
ATR0.5232
Shares Float844K
Short Float36.04%
Short Ratio0.09
Volatility0.98
Rel Volume0.07
Performance History
Week+11.49%
Month+9.27%
Quarter-27.95%
6 Months-66.33%
YTD-52.79%
Year-80.81%
3 Years-98.94%
5 Years-99.80%
10 Years-99.92%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $1.65 457,000
2026-06-17 $1.85 805,500
2026-06-16 $1.84 2,901,300
2026-06-15 $2.49 47,331,200
2026-06-12 $1.36 140,500
2026-06-11 $1.48 107,600
2026-06-10 $1.55 170,400
2026-06-09 $1.42 570,200
2026-06-08 $1.46 1,137,700
2026-06-05 $1.59 333,300
2026-06-04 $1.79 564,000
2026-06-03 $1.86 450,000
2026-06-02 $2.02 1,028,100
2026-06-01 $2.02 3,112,300
2026-05-29 $3.00 57,104,400
2026-05-28 $1.37 18,590,700
2026-05-27 $1.35 27,000
2026-05-26 $1.34 86,200
2026-05-22 $1.49 113,800
2026-05-21 $1.45 870,700
2026-05-20 $1.61 2,738,100
2026-05-19 $1.51 16,000
About PRF Technologies Ltd.

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $55,000 $0 $0 -
Cost Of Revenue $70,000 $0 $0 -
Total Revenue $17,000 $0 $0 $0
Operating Revenue $17,000 $0 $0 $0
Expenses
Total Expenses $5,139,000 $14,673,000 $9,584,000 $8,869,000
Rent Expense Supplemental $180,000 $146,000 $191,000 $249,000
Other Income Expense $-2,000 $6,000 $1,728,000 $-61,000
Net Non Operating Interest Income Expense $110,000 $87,000 $-1,480,000 $147,000
Total Other Finance Cost $10,000 $14,000 $1,886,000 $13,000
Operating Expense $5,069,000 $14,673,000 $9,584,000 $8,869,000
Selling And Marketing Expense $163,000 $0 $0 -
General And Administrative Expense $3,011,000 $2,968,000 $3,549,000 $4,447,000
Interest Expense - - - $0
Interest Expense Non Operating - - - $0
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-5,022,000 $-14,588,000 $-9,344,000 $-8,792,000
Net Interest Income $110,000 $87,000 $-1,480,000 $147,000
Interest Income $120,000 $101,000 $406,000 $160,000
Normalized Income $-5,020,460 $-14,592,620 $-10,674,560 $-8,745,030
Net Income From Continuing And Discontinued Operation $-5,022,000 $-14,588,000 $-9,344,000 $-8,792,000
Total Operating Income As Reported $-5,122,000 $-14,673,000 $-9,584,000 $-8,869,000
Net Income Common Stockholders $-5,022,000 $-14,588,000 $-9,344,000 $-8,792,000
Net Income $-5,022,000 $-14,588,000 $-9,344,000 $-8,792,000
Net Income Including Noncontrolling Interests $-5,022,000 $-14,588,000 $-9,344,000 $-8,792,000
Net Income Continuous Operations $-5,022,000 $-14,588,000 $-9,344,000 $-8,792,000
Pretax Income $-5,014,000 $-14,580,000 $-9,336,000 $-8,783,000
Interest Income Non Operating $120,000 $101,000 $406,000 $160,000
Operating Income $-5,122,000 $-14,673,000 $-9,584,000 $-8,869,000
Depreciation Amortization Depletion Income Statement $759,000 - - -
Depreciation And Amortization In Income Statement $759,000 - - -
Amortization Of Intangibles Income Statement $759,000 - - -
Gross Profit $-53,000 $0 $0 -
Per Share
Diluted EPS - $-105.52 $-122.94 $-317.30
Basic EPS - $-105.52 $-122.94 $-317.30
Other
Tax Effect Of Unusual Items $-460 $1,380 $397,440 $-14,030
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-4,346,000 $-14,663,000 $-11,297,000 $-8,793,000
Total Unusual Items $-2,000 $6,000 $1,728,000 $-61,000
Total Unusual Items Excluding Goodwill $-2,000 $6,000 $1,728,000 $-61,000
Reconciled Depreciation $774,000 $16,000 $15,000 $15,000
EBITDA (Bullshit earnings) $-4,348,000 $-14,657,000 $-9,569,000 $-8,854,000
EBIT $-5,122,000 $-14,673,000 $-9,584,000 $-8,869,000
Diluted NI Availto Com Stockholders $-5,022,000 $-14,588,000 $-9,344,000 $-8,792,000
Tax Provision $8,000 $8,000 $8,000 $9,000
Gain On Sale Of Security $-2,000 $6,000 $1,728,000 $-61,000
Amortization $759,000 - - -
Research And Development $1,136,000 $11,705,000 $6,035,000 $4,422,000
Selling General And Administration $3,174,000 $2,968,000 $3,549,000 $4,447,000
Other Gand A $1,543,000 $1,514,000 $1,356,000 $1,661,000
Insurance And Claims $168,000 $263,000 $394,000 $653,000
Rent And Landing Fees $180,000 $146,000 $191,000 $249,000
Salaries And Wages $1,120,000 $1,045,000 $1,608,000 $1,884,000
Diluted Average Shares - $138,254 $76,005 $27,709
Basic Average Shares - $138,254 $76,005 $27,709
Fetched: 2026-06-17
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $952,000 $1,824,000 $7,239,000 $11,021,000
Total Assets $11,998,000 $4,525,000 $9,930,000 $12,328,000
Total Non Current Assets $7,647,000 $97,000 $131,000 $44,000
Goodwill And Other Intangible Assets $7,591,000 $0 - -
Other Intangible Assets $7,405,000 - - -
Current Assets $4,351,000 $4,428,000 $9,799,000 $12,284,000
Other Current Assets $7,000 - - $310,000
Restricted Cash $25,000 $10,000 $10,000 $10,000
Prepaid Assets $36,000 $38,000 $1,718,000 $2,038,000
Receivables $142,000 $119,000 $45,000 $55,000
Other Receivables $142,000 $119,000 $45,000 $55,000
Cash Cash Equivalents And Short Term Investments $4,141,000 $4,261,000 $8,026,000 $10,181,000
Cash And Cash Equivalents $3,125,000 $4,261,000 $8,026,000 $4,096,000
Debt
Total Debt $21,000 $45,000 $86,000 -
Current Debt And Capital Lease Obligation $21,000 $45,000 $56,000 -
Long Term Debt And Capital Lease Obligation - $0 $30,000 -
Liabilities
Total Liabilities Net Minority Interest $2,708,000 $2,701,000 $2,691,000 $1,307,000
Total Non Current Liabilities Net Minority Interest $267,000 $259,000 $281,000 $243,000
Non Current Deferred Liabilities $267,000 $259,000 $251,000 $243,000
Non Current Deferred Taxes Liabilities $267,000 $259,000 $251,000 $243,000
Current Liabilities $2,441,000 $2,442,000 $2,410,000 $1,064,000
Payables And Accrued Expenses $2,081,000 $2,200,000 $1,889,000 $565,000
Payables $213,000 $296,000 $221,000 $209,000
Accounts Payable $213,000 $296,000 $221,000 $209,000
Equity
Common Stock Equity $8,543,000 $1,824,000 $7,239,000 $11,021,000
Total Equity Gross Minority Interest $9,290,000 $1,824,000 $7,239,000 $11,021,000
Stockholders Equity $8,543,000 $1,824,000 $7,239,000 $11,021,000
Retained Earnings $-61,289,000 $-56,451,000 $-41,863,000 $-32,519,000
Other
Ordinary Shares Number $402,628 $294,282 $14,402 $8,861
Share Issued $402,628 $294,282 $14,402 $8,861
Tangible Book Value $952,000 $1,824,000 $7,239,000 $11,021,000
Invested Capital $8,543,000 $1,824,000 $7,239,000 $11,021,000
Working Capital $1,910,000 $1,986,000 $7,389,000 $11,220,000
Capital Lease Obligations $21,000 $45,000 $86,000 -
Total Capitalization $8,543,000 $1,824,000 $7,239,000 $11,021,000
Minority Interest $747,000 $0 - -
Additional Paid In Capital $69,832,000 $58,275,000 $49,102,000 $43,446,000
Capital Stock $0 $0 $0 $94,000
Common Stock $0 $0 $0 $94,000
Current Capital Lease Obligation $21,000 $45,000 $56,000 -
Pensionand Other Post Retirement Benefit Plans Current $339,000 $197,000 $465,000 $499,000
Current Accrued Expenses $1,868,000 $1,904,000 $1,668,000 $356,000
Goodwill $186,000 $0 - -
Net PPE $56,000 $97,000 $131,000 $44,000
Gross PPE $56,000 $97,000 $131,000 -
Other Properties $30,000 $35,000 $38,000 -
Buildings And Improvements $26,000 $62,000 $93,000 -
Properties $0 $0 $0 -
Other Short Term Investments $1,016,000 $0 $0 $6,085,000
Long Term Capital Lease Obligation - $0 $30,000 -
Treasury Shares Number - - $0 -
Fetched: 2026-06-17
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-3,957,000 $-12,634,000 $-6,688,000 $-6,465,000
Operating Activities
Operating Cash Flow $-3,955,000 $-12,621,000 $-6,679,000 $-6,459,000
Cash Flow From Continuing Operating Activities $-3,955,000 $-12,621,000 $-6,679,000 $-6,459,000
Operating Gains Losses $2,000 $-6,000 $-1,360,000 -
Investing Activities
Capital Expenditure $-2,000 $-13,000 $-9,000 $-6,000
Investing Cash Flow $-982,000 $-13,000 $5,991,000 $-6,006,000
Cash Flow From Continuing Investing Activities $-982,000 $-13,000 $5,991,000 $-6,006,000
Financing Activities
Issuance Of Capital Stock $4,008,000 $5,350,000 $1,703,000 $0
Financing Cash Flow $3,818,000 $8,863,000 $4,616,000 $0
Cash Flow From Continuing Financing Activities $3,818,000 $8,863,000 $4,616,000 $0
Net Other Financing Charges $-190,000 $-1,235,000 $-932,000 -
Net Common Stock Issuance $4,008,000 $5,350,000 $1,703,000 $0
Common Stock Issuance $4,008,000 $5,350,000 $1,703,000 $0
Other
End Cash Position $3,150,000 $4,271,000 $8,036,000 $4,106,000
Beginning Cash Position $4,271,000 $8,036,000 $4,106,000 $16,571,000
Effect Of Exchange Rate Changes $-2,000 $6,000 $2,000 $0
Changes In Cash $-1,119,000 $-3,771,000 $3,928,000 $-12,465,000
Proceeds From Stock Option Exercised $0 $4,748,000 $3,845,000 $0
Net Investment Purchase And Sale $-1,000,000 $0 $6,000,000 $-6,000,000
Purchase Of Investment $-1,000,000 $0 $-1,000,000 $-6,000,000
Net Business Purchase And Sale $20,000 - - -
Sale Of Business $20,000 - - -
Net PPE Purchase And Sale $-2,000 $-13,000 $-9,000 $-6,000
Purchase Of PPE $-2,000 $-13,000 $-9,000 $-6,000
Change In Working Capital $-152,000 $1,657,000 $1,628,000 $672,000
Change In Payables And Accrued Expense $-130,000 $52,000 $1,298,000 $316,000
Change In Accrued Expense $113,000 $-24,000 $1,286,000 $243,000
Change In Payable $-243,000 $76,000 $12,000 $73,000
Change In Account Payable $-243,000 $76,000 $12,000 $73,000
Change In Prepaid Assets $-22,000 $1,605,000 $330,000 $356,000
Other Non Cash Items $-4,000 $-10,000 $1,578,000 $257,000
Stock Based Compensation $447,000 $310,000 $804,000 $1,389,000
Depreciation Amortization Depletion $774,000 $16,000 $15,000 $15,000
Depreciation And Amortization $774,000 $16,000 $15,000 $15,000
Amortization Cash Flow $759,000 - - -
Amortization Of Intangibles $759,000 - - -
Depreciation $15,000 $16,000 $15,000 $15,000
Net Foreign Currency Exchange Gain Loss $2,000 $-6,000 $-2,000 $0
Net Income From Continuing Operations $-5,022,000 $-14,588,000 $-9,344,000 $-8,792,000
Sale Of Investment - $0 $7,000,000 -
Gain Loss On Investment Securities - - $-1,358,000 -
Issuance Of Debt - - - -
Net Issuance Payments Of Debt - - - -
Net Long Term Debt Issuance - - - -
Long Term Debt Issuance - - - -
Change In Other Current Assets - - - -
Fetched: 2026-06-17